Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04184505 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)

Study acronym: ACROBAT
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 29, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Mar 1, 2024 to Mar 1, 2026
    • Study sites: 20 to 46
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2020 to Nov 27, 2020
    v3
  3. Start date: Mar 1, 2020 to Nov 2020v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Open-label, randomized multicenter phase III non-inferiority study
Trial Details
NCT Number NCT04184505
Lead Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions
(from sponsor)		 High-risk MDS
Enrollment 274 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov